F-star’s (FSTX) Delayed Acquisition Presents A Risky Opportunity
filadendron/E+ via Getty Images F-star Therapeutics (NASDAQ:FSTX) is a microcap company with macrocap dreams and a takeover bid at $7.12 per share. The company currently trades at $5.86. The gap remains on concern that although […]
